Tzu-Fei Wang
@tzufeiwang
Thrombosis and benign hematology physician at the Ottawa Hospital
ID: 1417282949767172098
20-07-2021 00:40:14
149 Tweet
348 Takipçi
106 Takip Edilen
Post-hoc analysis of the Hokusai VTE Cancer trial showed that treatment for recurrent VTE on AC were heterogeneous, and there were high risks of second recurrent VTE (9%) and major bleeding (10%) within 3 months! doi.org/10.1016/j.jtha… JTH Gary Raskob Marc Carrier
